SEC Form 4 · accession 0001209191-17-012367
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederic Pla
Officer — Chief Bus & Prod Dev Officer
Period of report
Feb 15, 2017
Accepted (ET)
Feb 17, 2017 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2017 | F | 2,882 | $31.12 | D | 31,700 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes an aggregate of 19,083 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.